3psx
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
{{STRUCTURE_3psx| PDB=3psx | SCENE= }} | {{STRUCTURE_3psx| PDB=3psx | SCENE= }} | ||
===Crystal structure of the KT2 mutant of cytochrome P450 BM3=== | ===Crystal structure of the KT2 mutant of cytochrome P450 BM3=== | ||
+ | {{ABSTRACT_PUBMED_21603690}} | ||
==Function== | ==Function== | ||
Line 6: | Line 7: | ||
==About this Structure== | ==About this Structure== | ||
- | [[3psx]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | [[3psx]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Atcc_14581 Atcc 14581]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3PSX OCA]. |
==See Also== | ==See Also== | ||
*[[Cytochrome P450|Cytochrome P450]] | *[[Cytochrome P450|Cytochrome P450]] | ||
- | [[Category: | + | *[[NADPH-Cytochrome P450 Reductase|NADPH-Cytochrome P450 Reductase]] |
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:021603690</ref><references group="xtra"/><references/> | ||
+ | [[Category: Atcc 14581]] | ||
[[Category: Unspecific monooxygenase]] | [[Category: Unspecific monooxygenase]] | ||
[[Category: Bartlam, M.]] | [[Category: Bartlam, M.]] |
Revision as of 07:40, 18 December 2013
Contents |
Crystal structure of the KT2 mutant of cytochrome P450 BM3
Template:ABSTRACT PUBMED 21603690
Function
[CPXB_BACME] Functions as a fatty acid monooxygenase. Catalyzes hydroxylation of medium and long-chain fatty acids at omega-1, omega-2 and omega-3 positions, with optimum chain lengths of 12-16 carbons (lauric, myristic, and palmitic acids). The reductase domain is required for electron transfer from NADP to cytochrome P450.
About this Structure
3psx is a 2 chain structure with sequence from Atcc 14581. Full crystallographic information is available from OCA.
See Also
Reference
- Whitehouse CJ, Yang W, Yorke JA, Tufton HG, Ogilvie LC, Bell SG, Zhou W, Bartlam M, Rao Z, Wong LL. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant. Dalton Trans. 2011 Oct 28;40(40):10383-96. doi: 10.1039/c1dt10098j. Epub 2011 May, 20. PMID:21603690 doi:http://dx.doi.org/10.1039/c1dt10098j